Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

University of California, Irvine

Division of University of California
www.uci.edu

Latest From University of California, Irvine

How Ovarian Cancer Maintenance Therapies Stack Up On Costs And Value

With new branded immunotherapy-based double- or triple-drug combinations on the way, there is greater scrutiny of costs and efficiency.

Cost Effectiveness Market Access

Tech Transfer Roundup: Amgen Teams With MD Anderson To Accelerate Early-Stage Cancer Candidates

In a busy month, MD Anderson also partners with Ipsen on an unspecified cancer drug and licenses poziotinib IP to Spectrum. Using IP from UCLA, Bloom launches with focus on neuroprotective epilepsy therapies.

Deals Intellectual Property

Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics

Canaan raised $800m for tech and health care investments. Also, six companies closed VC rounds, CARB-X backed more antibiotics, CIRM funded BrainStorm and Sarepta led recent offerings.

Financing Business Strategies

PhageTech Inc.

A handheld biosensor in development by PhageTech Inc. is designed to detect the presence of several biomarkers associated with the recurrence of bladder cancer from a small urine sample, without the need for expensive and time-consuming lab-based tests. The device could also monitor treatment.

Medical Device
See All
UsernamePublicRestriction

Register